Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.
The Scientist
Most Recent
Normal proteins with regions resembling disease-causing prions are responsible for an inherited disorder that affects the brain, muscle, and bone.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Inducing certain brain patterns extends non-REM sleep in mice.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
Children with dyslexia have an easier time learning to read after playing action video games that don’t incorporate reading.
Blind tadpoles regain vision when new eyes are grafted onto their tails.
Transplanting mouse neurons into rats allows the neurons to survive twice as long as they would in mice.
The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
